Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GAIA-Health

Financiado

Cerrado

GAIA Health microbiome suite for personalized medicine

GAIA-Health: microbiome suite for personalized medicine Genomic revolution is transforming our approach to treat patients by individualizing treatments that reduce adverse events and in turn decrease health care costs. Microbiome... ver más

30/11/2019

SEQUENTIA BIOTECH

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

SEQUENTIA BIOTECH Investigacion,desarrollo e innovacion,actividades cientificas y tecnicas,informacion y comunicacines,informatica,telecomunicaciones y ofimat...

TRL 4-5 | 130K€

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-11-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

SEQUENTIA BIOTECH

50.00K€ | Lider

NANOINNOVA TECHNOLOGIES

278.74K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PDC2021-121243-I00 PLATAFORMA DELFOS: SISTEMA DE INFORMACION PARA LA GESTION DE... 102K€ Cerrado

DIAMONDS Diagnosis and Management of Febrile Illness using RNA Person... 24M€ Cerrado

BiomeDxRx Microbiome-based diagnostics and therapeutics 150K€ Cerrado

PRE2019-089807 REVISANDO LA REPLICABILIDAD GENETICA MEDIANTE UN ENFOQUE MUL... 98K€ Cerrado

MultipleMS Multiple manifestations of genetic and non genetic factors i... 15M€ Cerrado

SAF2017-90781-REDI FOMENTO DEL USO DE LAS TECNOLOGIAS OMICAS EN MEDICINA PERSON... 79K€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2019-05-06
Fecha Fin: 2019-11-30

Líder del proyecto

SEQUENTIA BIOTECH Investigacion,desarrollo e innovacion,actividades cientificas y tecnicas,informacion y comunicacines,informatica,telecomunicaciones y ofimat...

TRL 4-5 | 130K€

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto GAIA-Health: microbiome suite for personalized medicine Genomic revolution is transforming our approach to treat patients by individualizing treatments that reduce adverse events and in turn decrease health care costs. Microbiome analysis can in fact be used for diagnosis and potentially prognosis of various diseases such as cancer, Crohn’s disease, metabolic disorders, reproductive health and skin pathologies and infections, as well as autoimmune, respiratory and mental diseases. Due to its broad adoption in a variety of medical and biotech domains, the global human microbiome market is witnessing an annual growth rate (CAGR) of 18,5%. However, the the cost and the complexity of microbiome data analysis and management represents the main bottleneck in this market, preventing a broader adoption of personalized medicine and diagnostic, as well as the discovery of new therapeutic targets where there is a lack of treatments for specific diseases. Our product - GAIA Health - bridges the gap between data production and interpretation in the health, diagnostic and biotech sector. Gaia-Health is a cutting edge omics tool that is able to detect, quantify and evaluate the biological composition of any type of sample of human microbiome (gut, skin, mouth and biofluid). GAIA Health offers unique insights into human health. It is the solution for every customer who needs customized microbiome analysis with superior precision and detection power, for faster, easier and effective personalized medicine, treatments and therapies. GAIA-Health stands apart from its competitors because of its superior precision and detection power; a Multi-diagnosis system - for this first type Gut, Skin, Mouth and Reproductive Health Analysis in one suite; and its Immediately actionable results, allowing faster and more reliable decision making .

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores